FDA Clearance Tracker · K260342
AllTest Strep A Rapid Test
Last checked: Nov 19, 2026Latest source record: Apr 30, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Apr 30, 2026
Substantially Equivalent
Time to decision
87 days
Received Feb 2, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K260342
- Device name
- AllTest Strep A Rapid Test
- Applicant
- Hangzhou AllTest Biotech Co., Ltd.
- Applicant location
- Hangzhou, CN
- Received
- Feb 2, 2026
- Decided
- Apr 30, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class I
- Regulation
- 21 CFR 866.3740
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GTY. The earliest in FDA's data is K812808, decided Dec 30, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260342
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Hangzhou AllTest Biotech Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252607 · Decided Oct 30, 2025 · 73 days after receipt
Device type: Diazo (Colorimetric), Nitrite (Urinary, Non-Quant) (JMT) · Laboratory Medicine & Pathology
K251053 · Decided Jul 15, 2025 · 102 days after receipt
Device type: Kit, Test, Pregnancy, Hcg, Over The Counter (LCX) · Laboratory Medicine & Pathology
K242576 · Decided Apr 4, 2025 · 218 days after receipt
Device type: Culture Media, Non-Propagating Transport (JSM) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.